Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Sherwood Scientific Exhibits Solution for Enzyme-Based Diagnostic Testing in Remote Locations

Published: Tuesday, November 12, 2013
Last Updated: Tuesday, November 12, 2013
Bookmark and Share
Sherwood Scientific Ltd will exhibit the CHROMA Model 260uv Programmable Colorimeter for the first time at MEDICA 2013.

The instrument allows users to conduct enzyme-based tests in challenging and remote locations without access to a laboratory. Also on display at MEDICA will be Sherwood Scientific’s magnetic susceptibility balance and the model 926S Chloride analyser, both valuable and established tools in clinical applications.

The Model 260uv Programmable Colorimeter’s ability to operate in the near UV region makes it ideal for enzyme-based clinical diagnostic tests. Until recently, it has been difficult to run these tests on cost-efficient instruments while in the field. The 260uv Colorimeter is rugged and portable, and can run using a variety of power sources, including a 12V car battery, making it a prime solution for use in field hospitals and remote locations. In addition, the system can store up to 100 methods, allowing the use of most commercially available test kits and user-generated reagents, further increasing the convenience of the whole system.

Sherwood Scientific will also showcase its unique benchtop magnetic susceptibility balance at MEDICA. This well-established product is suited for use when analysing iron-coated contrast agents, such as those used in magnetic resonance imaging, and ensuring their compliance in line with pharmacopoeia monographs. Visitors to the stand will also have the opportunity to explore the use of the model 926S Chloride Analyser, highly regarded in the diagnosis of cystic fibrosis for more than 15 years.

“We are very much looking forward to attending MEDICA 2013,” said Jon Copsey, Marketing Manager at Sherwood Scientific Ltd. “This will be Sherwood Scientific’s first time exhibiting at the show, and we are excited to demonstrate how our systems can benefit users in clinical areas. We know that working in this sector can produce some unique challenges, and are confident that visitors to the stand will come away with valuable solutions.”

Visitors to MEDICA 2013 (20 - 23 November 2013, Düsseldorf Fairgrounds, Germany) can find Sherwood Scientific at Hall 01/E07.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
MRIs for Fetal Health
Algorithm could help analyze fetal scans to determine whether interventions are warranted.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Supercomputers Could Improve Cancer Diagnostics
Researchers push the boundaries of cancer research through high-performance computing to map the human immunone.
Transgenomic, Precipio Diagnostics Merger
Merger will creates a robust diagnostic platform focused on improving accuracy of cancer diagnoses.
Inflammation Test May Predict Cardiovascular Disease
An assessment combining measures of immune-cell responsiveness predicted cardiovascular problems in individuals who likely would have slipped under the radar.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Potential Urine Test for CJD
Researchers at the Medical Research Council (MRC) Prion Unit at UCL have found that it may be possible to determine whether or not a person has sporadic Creutzfeldt-Jakob Disease (sCJD) by testing their urine for the presence of abnormal prion proteins.
ReadCoor Launched to Commercialize 3D Sequencing Tech
ReadCoor will leverage the Wyss Institute’s method for simultaneously sequencing and mapping RNAs within cells and tissues to advance development of diagnostics.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos